Schlich Ltd +44(0) 1903 717001 info@schlich.co.uk
The First Glimmers after the Doom of the Brüstle Decision

The First Glimmers after the Doom of the Brüstle Decision

by | Oct 1, 2012 | Briefings, EPO, UK

Concern and apprehension have been rife for patentees and practitioners alike in light of the Brüstle decision, which set out the CJEU’s decision as to what is and what is not excluded from patentability by the morality provisions of the Biotech Directive. Even...
From Sheep to Sleep: Supplementary Patent Protection is Extended

From Sheep to Sleep: Supplementary Patent Protection is Extended

by | Oct 1, 2012 | UK

An important consideration in the development of a pharmaceutical or other biologically active product is gaining approval from regulators to market the product. The timescales involved in gaining approval can be daunting, particularly when they are compared with the...
EPO Rule Changes Update April 2011

EPO Rule Changes Update April 2011

by | Jan 1, 2011 | EPO

Deadlines for Filing Divisional Applications We have previously discussed the revised rules for filing divisional applications introduced with effect from 1 April 2010. These previous changes introduced a 24 month period for filing any divisional applications...